Electrolyte abnormalities are a frequent and potentially hazardous complication in the treatment of patients with congestive heart failure. Medical treatment with diuretics and/or digitalis, as well as neurohumoral activation most likely initiated by the compromised cardiac function, contributes to this alteration. The addition of potassium- and magnesium-sparing diuretics (triamterence, amiloride) to therapy with frusemide or hydrochlorothiazide is of possible value in preventing intracellular electrolyte abnormalities.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
patients congestive
8
congestive heart
8
heart failure
8
electrolyte abnormalities
8
triamterene preserve
4
preserve lymphocyte
4
lymphocyte magnesium
4
magnesium potassium
4
potassium patients
4
failure electrolyte
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!